|
|
||||||||
The Journal of Immunology, Vol 144, Issue 6 2295-2303, Copyright © 1990 by American Association of Immunologists
ARTICLES |
KJ Micklem, WP Stross, AC Willis, JL Cordell, M Jones and DY Mason
Nuffield Department of Pathology, John Radcliffe Hospital, Headington, Oxford, U.K.
The Third and Fourth International Workshops on Leucocyte Differentiation Antigens identified six mAb, designated CDw32, reacting with human Ig FcR type II (FcRII). We have examined the immunohistochemical and immunocytologic reactivities of these antibodies and find that the antibodies could be divided into three classes of reactivity: 1) antibodies IV.3, CIKM3, and CIKM5 reacted with monocytes, macrophages and neutrophils; 2) antibodies KB61 and 41H.16 gave strong reactions with B lymphocytes, placental and hepatic endothelium, and weaker reactions with monocytes, macrophages, and neutrophils; 3) antibody 2E1 gave an intermediate reaction pattern. Immunoprecipitation from U937 cell lysates showed that antibodies KB61 and 41H.16 recognized Mr 41,000 and Mr 37,000 molecules whereas the other antibodies detected a Mr 42,000 molecule. Preclearing with antibody KB61 removed the Ag recognized by the other five antibodies confirming the identity of the Ag and demonstrating reactivity of KB61 with the Mr 42,000 molecule. Antibodies KB61 and 41H.16 precipitated a Mr 41,000 molecule from B lymphocytes. Flow cytometry and immunoprecipitation studies of cells transfected with cDNA clones coding for two isoforms of FcRII showed that all six of the antibodies react with both transfectants but the only immunoprecipitations were obtained using KB61 and 41H.16 and one of the transfectants. The protein sequence of KB61 Ag isolated from leukemic B cells showed close homology with the proteins encoded by the cDNA clones but diverged in the intracytoplasmic carboxyl-terminal region. It was concluded that preferential recognition of one or more of the numerous isoforms of FcRII underlies the differing reaction patterns of CDw32 antibodies.
This article has been cited by other articles:
![]() |
K. M. Dhodapkar, D. Banerjee, J. Connolly, A. Kukreja, E. Matayeva, M. C. Veri, J. V. Ravetch, R. M. Steinman, and M. V. Dhodapkar Selective blockade of the inhibitory Fc{gamma} receptor (Fc{gamma}RIIB) in human dendritic cells and monocytes induces a type I interferon response program J. Exp. Med., June 11, 2007; 204(6): 1359 - 1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhao, C. L. Kepley, P. A. Morel, L. M. Okumoto, Y. Fukuoka, and L. B. Schwartz Fc{gamma}RIIa, Not Fc{gamma}RIIb, Is Constitutively and Functionally Expressed on Skin-Derived Human Mast Cells J. Immunol., July 1, 2006; 177(1): 694 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Honig, L. Rieger, M. Kapp, J. Dietl, and U. Kammerer Immunohistochemistry in Human Placental Tissue--Pitfalls of Antigen Detection J. Histochem. Cytochem., November 1, 2005; 53(11): 1413 - 1420. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takizawa, C. L. Anderson, and J. M. Robinson A Novel Fc{gamma}R-Defined, IgG-Containing Organelle in Placental Endothelium J. Immunol., August 15, 2005; 175(4): 2331 - 2339. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. North, M. Waner, A. Mizeracki, R. E. Mrak, R. Nicholas, J. Kincannon, J. Y. Suen, and M. C. Mihm Jr A Unique Microvascular Phenotype Shared by Juvenile Hemangiomas and Human Placenta Arch Dermatol, May 1, 2001; 137(5): 559 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Lyden, J. M. Robinson, S. Tridandapani, J.-L. Teillaud, S. A. Garber, J. M. Osborne, J. Frey, P. Budde, and C. L. Anderson The Fc Receptor for IgG Expressed in the Villus Endothelium of Human Placenta Is Fc{{gamma}}RIIb2 J. Immunol., March 15, 2001; 166(6): 3882 - 3889. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Metes, L. K. Ernst, W. H. Chambers, A. Sulica, R. B. Herberman, and P. A. Morel Expression of Functional CD32 Molecules on Human NK Cells Is Determined by an Allelic Polymorphism of the Fcgamma RIIC Gene Blood, April 1, 1998; 91(7): 2369 - 2380. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |